<DOC>
	<DOC>NCT02013934</DOC>
	<brief_summary>The objective of this study is to assess the benefit and tolerability of a probiotic product in subjects with increased susceptibility to common cold.</brief_summary>
	<brief_title>Probiotics in Prevention of Common Cold</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>males and females age 1870 years increased risk for common cold (at least 4 episodes within 12 months) commitment to adhere to former diet and physical activity commitment not to use any products that may influence the study outcome (e.g. immune suppressants/immune stimulants, including paramedication such as e.g. Echinacea, analgesics/antirheumatics, antiphlogistics, antitussives/expectorants, influenza remedies, mouth or throat therapeutics, decongestants, antibiotics, antihistaminergic drugs, probiotics) during the study (except for rescue medication, see 7.5) women of childbearing potential have to agree to use appropriate birth control methods Written consent of the subject to participate is a prerequisite for study participation. acute / chronic upper / lower airways disease chronic cough of any origin any allergic reaction that may influence the study outcome (e.g. acute/chronic rhinitis) history of nasal reconstructive surgery presence of nasal ulcers or nasal polyps severe nasal septum deviation or other condition that could cause nasal obstruction congenital or acquired immunodeficiency disease (e.g. HIV infection) Bechterew's disease body temperature above 37.5Â°C suspected swine flu or influenza vaccination with a vaccine containing an adjuvant within 3 months prior to study start and during the study vaccination with a vaccine not containing an adjuvant within 6 weeks prior to study start and during the study stomach/gastrointestinal diseases serious organ or systemic diseases sleep disorder psychiatric disorders known sensitivity to the ingredients of the investigational product regular intake of products that may influence the study outcome (e.g. immune suppressants/immune stimulants, including paramedication such as e.g. Echinacea, analgesics/antirheumatics, antiphlogistics, antitussives/expectorants, influenza remedies, mouth or throat therapeutics, decongestants, antibiotics, antihistaminergic drugs, probiotics) within the last 4 weeks prior to study start habitual usage of nasal drops/spray pregnancy or nursing alcohol / drug abuse simultaneous participation in another clinical trial or participation in a clinical trial within the last 30 days insufficient compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>